'First relapse' diaporamas de présentation

Multiple myeloma (MM)

Multiple myeloma (MM). The second most common adult haematological malignancy. MM is a clonal malignancy of terminally differentiated plasma cells. Multiple myeloma: Epidemiology and incidence. Annual incidence of approximately 30-50 per million.

1.34k views • 59 slides

DISULFIRAM Comparative Studies and Experiences from Clinical Practice

1.2k views • 46 slides

Diagnosis and Treatment of Multiple Myeloma

Diagnosis and Treatment of Multiple Myeloma. Mark B. Juckett MD Division of Hematology University of Wisconsin December 11, 2002. Introduction. Multiple myeloma is a clonal plasma cell neoplasm Usually accompanied by monoclonal antibody production 1% of all cancer Median age 65 years

939 views • 40 slides

Is there Long-Term Benefit from Maintenance Rituximab?

Is there Long-Term Benefit from Maintenance Rituximab?. Emanuele Zucca, MD Oncology Institute of Southern Switzerland (IOSI) Swiss Group for Clinical Cancer Research (SAKK). Rationale and aim of maintenance in haematological malignancies.

562 views • 37 slides

Chemotherapy Intensification by Interval Compression in Localized Ewing Sarcoma Family Tumors (ESFT)

1.18k views • 22 slides